参考文章(11)
Tae-Wan KIM, Mi-Na KIM, Jae-Woo KWON, Kyung-Mook KIM, Sae-Hoon KIM, Won KIM, Heung-Woo PARK, Yoon-Seok CHANG, Sang-Heon CHO, Kyung-Up MIN, You-Young KIM, Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids. Respirology. ,vol. 15, pp. 1092- 1097 ,(2010) , 10.1111/J.1440-1843.2010.01798.X
R. Tur-Kaspa, R. D. Burk, Y. Shaul, D. A. Shafritz, Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 1627- 1631 ,(1986) , 10.1073/PNAS.83.6.1627
Ching-Lung Lai, Man-Fung Yuen, What Is the Best End Point for Hepatitis B Treatment Annals of Internal Medicine. ,vol. 148, pp. 560- 560 ,(2008) , 10.7326/0003-4819-148-7-200804010-00014
Ching-Lung Lai, Man-Fung Yuen, Chronic Hepatitis B — New Goals, New Treatment The New England Journal of Medicine. ,vol. 359, pp. 2488- 2491 ,(2008) , 10.1056/NEJME0808185
Yuriko KOGA, Ryukichi KUMASHIRO, Kiyoshi YASUMOTO, Satoshi SHAKADO, Noriyuki ONO, Hideya NOGUCHI, Kazuyoshi NAGATA, Michio SATA, Hirohiko ABE, Nobuo KAKU, Kyuichi TANIKAWA, Two fatal cases of hepatitis B virus carriers after corticosteroid therapy for bronchial asthma. Internal Medicine. ,vol. 31, pp. 208- 213 ,(1992) , 10.2169/INTERNALMEDICINE.31.208
Reginald G. Hanson, Marion G. Peters, Jay H. Hoofnagle, Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology. ,vol. 6, pp. 173- 179 ,(1986) , 10.1002/HEP.1840060204